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An outbreak of acute haemorrhagic 
conjunctivitis associated with coxsackievirus 
A24 variant in The Gambia, West Africa
Sarah E. Burr1,2* , Ansumana Sillah3, Hassan Joof2, Robin L. Bailey1 and Martin J. Holland1
Abstract 
Objective: An outbreak of acute haemorrhagic conjunctivitis occurred in The Gambia, West Africa in 2011. Affected 
individuals presented with conjunctival haemorrhages, swelling and ocular discharge. In an effort to identify a causa-
tive agent of the disease, ocular swabs were taken from patients during the acute and convalescent phases. Total RNA 
was extracted from all samples and reverse-transcriptase PCR performed using primers specific for all enteroviruses. 
Resulting amplicons were sequenced and data compared to known sequences using the BLAST algorithm.
Results: Forty-eight swabs were included in the analysis. Of these, 21 acute and 9 convalescent swabs (65% of the 
total) gave positive PCR results. Sequence analysis of the resulting amplicons indicated 99% sequence identity with 
coxsackievirus A24 variant identified during independent outbreaks of acute haemorrhagic conjunctivitis around the 
world and suggest the Gambian outbreak was due to this virus.
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Introduction
Acute haemorrhagic conjunctivitis (AHC) was first 
described in Ghana in 1969 [1]. Its appearance coin-
cided with the first Apollo moon landing prompting the 
Ghanaians to give it the name Apollo 11 Disease [2]. The 
etiological agent in this outbreak was identified as enter-
ovirus 70 (EV70) [2, 3]. In the following year, an outbreak 
of Apollo was described in Singapore [4] however, in this 
case, the cause was determined to be a coxsackievirus 
A24 variant (CVA24v) [5]. Since then numerous reports 
of AHC have emerged from across the world, associated 
with either EV70 or CVA24v. These two viruses are now 
recognized as the primary agents of AHC [6].
AHC is not uncommon in The Gambia, West Africa 
with large-scale outbreaks occurring every few years. 
This is likely due to the breakdown of heard immunity 
as levels of neutralizing antibodies steadily decrease in 
the years following infection [7]. AHC usually resolves 
without sequelae, although secondary corneal infection 
has been reported after treatment with topical steroids 
[8]. In The Gambia however, most individuals do not seek 
treatment for the disease within the health care system 
but rather self-administer traditional treatments than can 
include applying lemon juice, paste of chili peppers or 
urine to the eyes, often further exacerbating clinical signs 
of disease.
In August 2011, an outbreak of AHC began in The 
Gambia and rapidly spread across the country. Infected 
individuals presented with conjunctival haemorrhages, 
conjunctival swelling and ocular discharge. As no formal 
reporting structure for AHC exists in The Gambia and 
given the lack of laboratory facilities in the country, little 
else is know about the outbreak.
We hypothesized that individuals with clinical signs 
of AHC would have ocular infection with either EV70 
or CVA24v. In an effort to determine if either of these 
viruses were the causative agent of the outbreak, ocu-
lar swabs were collected from individuals presenting 
with clinical signs of AHC during the acute phase of 
the disease and following a period of convalescence. 
These swabs were then processed using PCR and DNA 
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sequencing techniques. This represents the first identifi-
cation of a causative agent of AHC in The Gambia.
Main text
Ocular swabs were collected by convenience sampling of 
patients, residing in the Brikama and Mansakonko Local 
Government Areas (previously known as Western and 
Lower River Divisions), who presented with clinical signs 
of AHC to community eye health workers during a com-
munity screening exercise in September 2011, during the 
height of the outbreak. Inclusion criteria were the ability 
to provide informed consent, or in the case of minors, a 
parent or guardian willing to provide consent. Exclusion 
criteria were a pre-existing eye condition that prevented 
sample collection. Follow-up swabs were then collected 
for the same patients in December 2011, during the con-
valescent period. A total of 92 swabs were collected how-
ever, due to logistical and financial constraints, only 28 
swabs collected from patients during the acute phase of 
the disease and an additional 20 from patients who were 
re-visited 3 months later were analysed in this study.
The age range of patients for whom samples were ana-
lysed was from 7 months to 65 years (mean = 10 years). 
Forty percent of these patients were female. All patients 
had clinical signs of AHC at the time the first swab was 
collected. One patient also had clinical signs of trachoma-
tous scarring. No individual had signs of AHC when the 
convalescent swabs were collected.
One field supervisor with dedicated eye-health training 
and over 20  years experience in community eye-health 
collected all samples. Samples were collected from the 
lower fornix using sterile, Dacron swabs (Puritan, Maine, 
USA) and placed into screw-top tubes containing RNAl-
ater (Thermo Fisher Scientific, Waltham, USA). Samples 
were held on wet ice in the field and frozen at –  70  °C 
within 12  h of collection. RNA was extracted using the 
QIAamp Viral RNA mini kit (QIAGEN, Hilden, Ger-
many) as per the manufacturer’s instructions. RNA was 
reverse-transcribed and the resulting DNA amplified by 
polymerase chain reaction (PCR) using the Quantitect 
Virus RT MasterMix (QIAGEN, Hilden, Germany) and 
primers S1 (5′ CAAGCACTTCTGTTTCCCCGG 3′) and 
AS-1 (5′ ATTGTCACCATAAGCAGCCA 3′), which are 
specific for enteroviruses [9]. A nested PCR reaction was 
then carried out using primers S2 (5′ TCCTCCGGCCC 
CTGAATGCG 3′) and AS-2 (5′ AAACACGGACACCC 
AAAGTA 3′), again specific for enteroviruses [9]. Result-
ing amplicons were separated by gel electrophoresis and 
visualized with ethidium bromide staining. Of 48 swabs 
assayed, 21 acute and 9 convalescent samples (65% of all 
samples) generated amplicons of expected size (approx-
imately 120 base pairs). Positive and negative PCR 
controls gave the expected results. Fisher’s exact test 
revealed a trend suggesting acute swabs were more likely 
to yield a positive PCR result than convalescent swabs 
(p = 0.0681), however this did not reach statistical signif-
icance when using a threshold for significance of p < 0.05.
Amplicons were subsequently purified and sent to 
Macrogen Inc. (Seoul, Korea) for Sanger sequencing. 
Sequencing chromatograms were edited manually using 
Sequencher 4.9 software (Gene Codes Corporation, Ann 
Arbor, MI, USA) and sequences were trimmed such that 
the first 25 bases contained less than 5 bases with con-
fidence scores below Q20. A 71 base pair consensus 
sequence, formed from data from 26 amplicons, was then 
constructed (Additional file 1). All samples revealed iden-
tical sequences except one, which had a single base pair 
substitution at position 38 (G instead of T).
A comparison of the consensus sequence with known 
data was carried out using BLAST [10] and revealed 99% 
sequence identity with CVA24v associated with recent 
outbreaks of AHC in Reunion Island (Indian Ocean) 
in 2015 (GenBank Accession No. KR399988, posi-
tions 492–563) [11], Japan in 2011 (GenBank Accession 
No. AB769164, positions 496–567) [12], China in 2007 
(GenBank Accession No. JF742579, positions 491–562) 
[13] and Singapore in 2005 (GenBank Accession No. 
DQ443002, positions 495–566) [14], all of which have 
been identified as belonging to genotype IV [11]. Eighty-
three percent identity was found with EV70, spanning 
position 489–561 of the reference (GenBank Accession 
No. D00820) [15] (Fig. 1).
Conclusions
Our data suggests that CVA24v was the causative agent 
of the outbreak of AHC, which occurred in The Gam-
bia in 2011. Community ophthalmic nurses can use this 
Fig. 1 Multiple sequence alignment generated in T-Coffee [16]. Consensus sequence data obtained from ocular swabs from Gambian patients 
presenting with acute haemorrhagic conjunctivitis (AHC) in comparison to CVA24v (GenBank Accession No. KR399988) and EV70 (GenBank Acces-
sion No. D00820)
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knowledge to educate people as to the cause of AHC, to 
promote simple hygiene measures to interrupt transmis-
sion and to advise more appropriate means of clinical 
care in future outbreaks.
Limitations
The greatest limitation of our study is the absence of 
swabs collected from individuals with normal eyes during 
the outbreak, which prevents us from saying CVA2a was 
the definitive cause of the AHC outbreak. That CVA24a 
was found in convalescent samples suggests the virus can 
persist in the eye for a significant period of time follow-
ing the resolution of clinical signs, however, we have not 
found any published reports of CVA24a being detected 
in normal eyes outside of AHC outbreaks.
Twenty-one of 28 acute swabs (75%) generated a posi-
tive PCR result. The apparent absence of CVA24a DNA 
in the remaining 7 acute swabs may be due to the sensi-
tivity of the test used, which was a nested PCR followed 
by visualization of amplified DNA by gel electrophoresis 
and ethidium bromide staining. It is possible that these 7 
individuals were not yet shedding viral DNA at the time 
of sample collection or were shedding loads that were 
below the sensitivity of the test. Misdiagnosis of AHC 
by the eye-health worker who collected the swabs is also 
a possible explanation however we feel this is unlikely 
given the severity of clinical signs observed and the con-
tagious nature of AHC.
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